OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Gastroenterology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
Small varices in chronic liver diseases	65
Medical malpractice and gastrointestinal endoscopy	35
Editorial introductions	34
Updates and innovations in therapeutic endoscopy	33
Editorial introductions	32
Biologics, small molecule therapies and surgery in small bowel Crohn's disease	31
Management of upper gastrointestinal symptoms in patients with autoimmune gastritis	30
Hepatitis E virus: has anything changed?	27
Clostridioides difficile infections; new treatments and future perspectives	26
Cholangioscopy for biliary diseases	25
Using nutrition to help recovery from infections	21
Stomach and duodenum: what's current in 2023	19
Double-edged sword: impact of fecal microbiome transplants on the gut resistome	18
Current and future microbiome-based therapies in inflammatory bowel disease	17
Editorial introductions	17
Role of hyperbaric oxygen therapy in patients with inflammatory bowel disease	17
Carnitine derivatives beyond fatigue: an update	16
Small bowel lymphoma: clinical update and challenges for the gastroenterologist	15
Considerations when starting patients on multiple biologics and small molecules	14
Refractory eosinophilic esophagitis: what to do when the patient has not responded to proton pump inhibitors, steroids and diet	14
Prognostic modeling in biliary diseases	14
Editorial: Clinical and pathogenic novelties in cholangiopathies: new treatments and many more to come	14
COVID-19 vaccine-induced liver injury	14
Interactions between the environmental and human microbiota in the preservation of health and genesis of disease: symposium report	14
The gut virome in health and disease: new insights and associations	13

Implications of Paneth cell dysfunction on gastrointestinal health and disease	13
A review of deep learning and radiomics approaches for pancreatic cancer diagnosis from medical imaging	13
Micronutrient status and protein-energy malnutrition in free-living older adults: a current perspective	13
Clinical and translational markers of severity and prognosis in chronic pancreatitis	13
Gastroparesis: time for a paradigm change	12
Cryptogenic multifocal ulcerating stenosing enteritis and other under-recognised small bowel inflammatory enteropathies	12
Endoluminal bariatric and metabolic therapies: state-of-the-art	11
Laparoscopic heller myotomy versus peroral endoscopic myotomy for the treatment of achalasia	11
Celiac disease and nonceliac enteropathies	11
Endoscopic management of colonic perforations	11
Role of albumin in the treatment of decompensated liver cirrhosis	11
Machine and deep learning in inflammatory bowel disease	11
Tight junction proteins and biliary diseases	11
Gastric submucosal mass lesions	11
Bidirectional relationship between acute pancreatitis and pancreatic cancer	11
Ergonomic wellness for the trainee in gastrointestinal endoscopy	11
Advances in endoscopic management of colonic diverticular bleeding	10
Artificial intelligence within the small bowel: are we lagging behind?	10
Bile acid diarrhea – as bad as it gets?	10
Editorial introductions	10
Managing the older adult with inflammatory bowel disease: is age just a number?	10
Advances in the evaluation and treatment of autoimmune hepatitis	10
Nutritional aspects in patients with gastroparesis	9
Alterations in microbiome associated with acute pancreatitis	9
Diagnosis and management of acute lower gastrointestinal bleeding	9
Histological evaluation in biliary diseases	9
Endoscopic approaches to the management of hemorrhoids	9
Intestinal proteases	9
Probiotics in irritable bowel syndrome and inflammatory bowel disease: review of mechanisms and effectiveness	9
Editorial: Advances in hepatology: 2022	8
Updates in endoscopic management of ampullary and duodenal adenomas	8
Check this out: treatment paradigms in immune-checkpoint inhibitor colitis	8
Pathophysiology updates: gastroduodenal injury and repair mechanisms	8
Updates on therapeutic endoscopic ultrasound	8
Should high-fiber diets be recommended for patients with inflammatory bowel disease?	8
Editorial introductions	8
The rise of antibiotic resistance in Campylobacter	8
Integrating new and emerging therapies into inflammatory bowel disease clinical practice	7
Endoscopic approaches to small intestinal strictures	7
The status of endoscopic therapies for gastroesophageal reflux disease	7
Neurological disorders and small bowel dysmotility	7
Diet and carcinogenesis of gastric cancer	7
Imaging abnormalities of the pancreas in diabetes: implications for diagnosis and treatment	7
Intestinal transplantation: an update	7
The spectrum of diabetes in acute and chronic pancreatitis	7
Update on applications of endoscopic cryotherapy in the gastrointestinal tract	7
Editorial: The next-generation toolkit for exploring biliary diseases	6
Bulking agents in gastrointestinal endoscopy: present applications and future advances	6
Neoadjuvant therapy in pancreatic cancer: a review and update on recent trials	6
Identifying individuals at risk of esophageal adenocarcinoma: challenges, existing tools and future steps	6

The vermiform cecal appendix, expendable or essential? A narrative review	6
Editorial introductions	6
Advances in colon-targeted drug technologies	6
How provocative tests in addition to wet swallows during high-resolution manometry can direct clinical management	6
Small bowel intussusception – aetiology & management	6
Endoscopic therapy for gastroesophageal reflux disease: where are we, where are we going?	6
Editorial introductions	6
Editorial introductions	6
Management of refractory inflammatory bowel disease	6
The use of artificial intelligence in colonoscopic evaluations	6
Update on extraesophageal manifestations of gastroesophageal reflux	6
Small intestinal bacterial overgrowth: current update	5
Retention of small bowel capsule endoscopy	5
Role of endoscopy on enteral feeding	5
Immune markers of severe acute pancreatitis	5
Risk and factors determining diabetes after mild, nonnecrotizing acute pancreatitis	5
Nutritional deficiencies in alcohol use disorder/alcohol-associated liver disease	5
Road map to small bowel endoscopy quality indicators	5
A ramble through the small bowel	5
Interpretation of serum pancreatic enzymes in pancreatic and nonpancreatic conditions	5
Small bowel Crohn's disease: optimal modality for diagnosis and monitoring	5
Intestinal microbiome in short bowel syndrome: diagnostic and therapeutic opportunities	5
Editorial: The future of inflammatory bowel disease management	5
Reviewing the impact of obesity on inflammatory bowel disease and considerations for optimizing management	5
The role of the microbiome in liver disease	5
Editorial: Stomach and duodenum: what is current in 2022?	5
Editorial introduction	5
Targeting osteopontin to treat primary sclerosing cholangitis	5
Editorial: Pathology in the small bowel – challenges, trials and tribulations	5
Mast cell activation and nutritional disorders in patients with hypermobility	5
Macrophages in cholangiopathies	4
Population level screening for celiac disease: is now the time?	4
Lichen planus esophagitis	4
Comparative efficacy trials in inflammatory bowel disease: current and future implications for practice	4
Endoscopic ultrasound-guided radiofrequency ablation of pancreatic tumors	4
Precision medicine: how multiomics will shape the future of inflammatory bowel disease?	4
Clostridium difficile in inflammatory bowel disease	4
Imaging of the biliary tract	4
A Practical guide to selecting and using new Crohn's disease therapies	4
The role of the fibroblast in Barrett's esophagus and esophageal adenocarcinoma	4
Colon polyps: updates in classification and management	4
Selection of endoscopic resection technique for large colorectal lesion treatment	4
Update on pain management in acute pancreatitis	4
The evaluation of liver abnormalities in inflammatory bowel disease patients	4
Bile acids as metabolic regulators: an update	4
Neuro-immune cell interactions in the regulation of intestinal immune homeostasis	4
Noninvasive evaluation of fibrosis in adult biliary diseases	4
Incretin mimetics and acute pancreatitis: enemy or innocent bystander?	4
Cellular senescence in the cholangiopathies	3
Editorial: The fight against infectious diseases begins anew	3
Editorial introductions	3
Healthcare disparities in pancreatitis: knowledge gaps and next steps	3
Inability to belch syndrome: what the gastroenterologist needs to know	3
Drug-induced bile duct injury: new agents, new mechanisms	3
Diet as a treatment for inflammatory bowel disease: is it ready for prime time?	3
The use of ultrasound in colonic and perianal diseases	3
Editorial introductions	3
Biomarkers for the diagnosis and monitoring of celiac disease: can you count on me?	3
Metabolic dysfunction and nonalcoholic fatty liver disease risk in individuals with a normal body mass index	3
A practical guide to selecting and using new ulcerative colitis therapies	3
Endobariatrics: well past infancy and maturing rapidly	3
Integrins in biliary injury and fibrosis	3
Small bowel obstruction: what a gastroenterologist needs to know	3
Editorial: food, nutrition and the microbiome in health and disease	3
Current opinion: functional dyspepsia	3